Search

Your search keyword '"Mariappan V"' showing total 236 results

Search Constraints

Start Over You searched for: Author "Mariappan V" Remove constraint Author: "Mariappan V"
236 results on '"Mariappan V"'

Search Results

201. Potential biomarkers for the early prediction of SARS-COV-2 disease outcome.

202. Hijacking of the Host's Immune Surveillance Radars by Burkholderia pseudomallei .

203. Expression dynamics of vascular endothelial markers: endoglin and syndecan-1 in predicting dengue disease outcome.

204. Angiotensin-converting enzyme 2: A protective factor in regulating disease virulence of SARS-COV-2.

205. Mitochondrial Dysfunction in Diabetic Cardiomyopathy: The Possible Therapeutic Roles of Phenolic Acids.

206. Experimental exposure of Burkholderia pseudomallei crude culture filtrate upregulates PD-1 on T lymphocytes.

207. Intracellular survival and innate immune evasion of Burkholderia cepacia: Improved understanding of quorum sensing-controlled virulence factors, biofilm, and inhibitors.

208. Prevalence and association of pks+ Escherichia coli with colorectal cancer in patients at the University Malaya Medical Centre, Malaysia.

209. Transcriptome analysis of Burkholderia pseudomallei SCV reveals an association with virulence, stress resistance and intracellular persistence.

210. Oxidative stress response in the pathogenesis of dengue virus virulence, disease prognosis and therapeutics: an update.

211. Polymorphisms in the host CYP2C19 gene and antibiotic-resistance attributes of Helicobacter pylori isolates influence the outcome of triple therapy.

212. Altered Platelet Fatty Acids in Dengue Cases by Gas Chromatography-Mass Spectrometry Analysis.

213. Relapse of chronic melioidosis in a paediatric cystic fibrosis patient: first case report from Malaysia.

214. Adhesion and invasion attributes of Burkholderia pseudomallei are dependent on airway surface liquid and glucose concentrations in lung epithelial cells.

215. Melioidosis in Malaysia: Incidence, Clinical Challenges, and Advances in Understanding Pathogenesis.

216. Host-Adaptation of Burkholderia pseudomallei Alters Metabolism and Virulence: a Global Proteome Analysis.

217. Survival and Intra-Nuclear Trafficking of Burkholderia pseudomallei: Strategies of Evasion from Immune Surveillance?

218. Antimicrobial activity of Tachyplesin 1 against Burkholderia pseudomallei : an in vitro and in silico approach.

219. Experimental Phage Therapy for Burkholderia pseudomallei Infection.

220. Burkholderia pseudomallei Differentially Regulates Host Innate Immune Response Genes for Intracellular Survival in Lung Epithelial Cells.

221. Molecular evidence of Burkholderia pseudomallei genotypes based on geographical distribution.

222. Altered Proteome of Burkholderia pseudomallei Colony Variants Induced by Exposure to Human Lung Epithelial Cells.

223. Comparative genomic analysis of Helicobacter pylori from Malaysia identifies three distinct lineages suggestive of differential evolution.

224. Enhanced intracellular survival and epithelial cell adherence abilities of Burkholderia pseudomallei morphotypes are dependent on differential expression of virulence-associated proteins during mid-logarithmic growth phase.

225. Himbacine-derived thrombin receptor antagonists: c7-spirocyclic analogues of vorapaxar.

226. Antimicrobial susceptibility and genetic characterisation of Burkholderia pseudomallei isolated from Malaysian patients.

227. Himbacine-derived thrombin receptor antagonists: c7-aminomethyl and c9a-hydroxy analogues of vorapaxar.

228. Assessment of compost as a bio-fertilizer for the growth of paddy.

229. Infection of Burkholderia cepacia induces homeostatic responses in the host for their prolonged survival: the microarray perspective.

230. Hypericin-photodynamic therapy leads to interleukin-6 secretion by HepG2 cells and their apoptosis via recruitment of BH3 interacting-domain death agonist and caspases.

231. Burkholderia vaccines: are we moving forward?

232. Discovery of nor-seco himbacine analogs as thrombin receptor antagonists.

233. Identification of immunoreactive secretory proteins from the stationary phase culture of Burkholderia pseudomallei.

234. Profiling of Burkholderia cepacia secretome at mid-logarithmic and early-stationary phases of growth.

235. Identification of immunogenic proteins from Burkholderia cepacia secretome using proteomic analysis.

236. Heterotricyclic himbacine analogs as potent, orally active thrombin receptor (protease activated receptor-1) antagonists.

Catalog

Books, media, physical & digital resources